publication date: Jun. 5, 2015

ASCO CEO Allen Lichter to Step Down in June 2016


Allen Lichter, CEO of the American Society of Clinical Oncology and the Conquer Cancer Foundation of ASCO, announced June 1 that he would step down June 30, 2016.

Lichter has led ASCO since 2006.

On Lichter’s watch, ASCO’s total revenues grew from about $71 million in fiscal 2006 to $93 million in fiscal 2013, the most recent year for which data are publicly available.

The ASCO board of directors has selected a search advisory committee, led by ASCO President Julie Vose.

“ASCO expects the search to begin in September, which will give the committee plenty of time to find the very best candidate to lead the organization,” ASCO officials said in a statement to The Cancer Letter.

Prior to becoming ASCO CEO, Lichter held two leadership roles at the University of Michigan—he was chair and professor of Radiation Oncology from 1984 to 1998 and dean of the medical school from 1998 to 2006.

At the University of Michigan, Lichter was the first Isadore Lampe Professor of Radiation Oncology, an endowed chair, and was the Newman Family Professor of Radiation Oncology. He previously served as the director of the Radiation Therapy Section of the NCI Radiation Oncology Branch.

Lichter’s research and development of three-dimensional treatment planning led to a Gold Medal from the American Society for Radiation Oncology.

In 2002, Lichter was elected to the Institute of Medicine of the National … Continue reading 41-22 ASCO CEO Allen Lichter to Step Down in June 2016

To access this members-only content, please log in.
Institutional subscribers, please log in with your IP.
If you're not a subscriber why not join today?
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.
Click here to join.

Copyright (c) 2020 The Cancer Letter Inc.